Vitamin B-6 normalizes the altered sulfur amino acid status of rats fed diets containing pharmacological levels of niacin without reducing niacin's hypolipidemic effects

被引:36
作者
Basu, TK [1 ]
Mann, S [1 ]
机构
[1] UNIV ALBERTA, DEPT AGR FOOD & NUTR SCI, EDMONTON, AB T6G 2P5, CANADA
关键词
niacin; hypolipidemic actions; vitamin B-6; sulfur amino acids; hyperhomocysteinemia; hypocysteinemia; rats;
D O I
10.1093/jn/127.1.117
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Niacin (nicotinic acid) in large doses (>2 g) has been increasingly the choice of lipid-lowering agent by clinicians. However, the potential risks of the use of high doses of the vitamin have not been critically considered in the same way as has the use of other lipid-lowering drugs. The present study provides evidence that pharmacological levels of niacin interfere with the metabolism of methionine, leading to hyperhomocysteinemia and hypocysteinemia. Male Sprague-Dawley rats were fed a semisynthetic diet supplemented with either 400 or 4000 mg niacin/kg (compared with 47 mg/kg diet in the control diet). In Experiment 1, feeding these diets for 3 wk resulted in a dose-related increase in the plasma and urine methionine concentrations while cysteine levels were decreased. This altered methionine metabolism was accompanied by a lower plasma vitamin B-6 concentration in niacin-supplemented rats compared with controls. In Experiment 2, the methionine and cysteine levels in plasma and urine were normalized when vitamin B-6 (10 mg/kg diet) was added to the diet containing 4000 mg niacin/kg and led for 6 wk. This experiment also showed that plasma and urine homocysteine concentrations were increased by niacin and normalized by vitamin B-6. The hypolipidemic action of niacin was unaffected by the presence of vitamin B-6. These results indicate that niacin at large dosages interferes with methionine metabolism by affecting vitamin B-6 status. The treatment of dyslipidemia with simultaneous administration of niacin and vitamin B-6 could be a better therapy than the use of niacin alone.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 28 条
  • [1] [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
  • [2] BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS
    BLANKENHORN, DH
    NESSIM, SA
    JOHNSON, RL
    SANMARCO, ME
    AZEN, SP
    CASHINHEMPHILL, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23): : 3233 - 3240
  • [3] BLEILER RE, 1962, J LAB CLIN MED, V59, P945
  • [4] BRATTSROM LE, 1986, J NUTR, V126, pS1276
  • [5] ELEVATED PLASMA HOMOCYST(E)INE CONCENTRATION AS A POSSIBLE INDEPENDENT RISK FACTOR FOR STROKE
    COULL, BM
    MALINOW, MR
    BEAMER, N
    SEXTON, G
    NORDT, F
    DEGARMO, P
    [J]. STROKE, 1990, 21 (04) : 572 - 576
  • [6] DIPALMA JR, 1991, ANNU REV NUTR, V11, P169, DOI 10.1146/annurev.nu.11.070191.001125
  • [7] NICOTINIC-ACID FOR THE TREATMENT OF HYPERLIPOPROTEINEMIA
    DROOD, JM
    ZIMETBAUM, PJ
    FRISHMAN, WH
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (07) : 641 - 650
  • [8] FRILDWALD WT, 1972, CLIN CHEM, V18, P499
  • [9] GRUNDY SM, 1981, J LIPID RES, V22, P24
  • [10] Homocysteine and hemostasis: Pathogenetic mechanisms predisposing to thrombosis
    Harpel, PC
    Zhang, XX
    Borth, W
    [J]. JOURNAL OF NUTRITION, 1996, 126 (04) : S1285 - S1289